Felix B. Salazar
- Oncology top 5%
- Immunology top 5%
- Biomedical Engineering top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Co-authors
- Anna M. WuRichard TavaréKirstin A. ZettlitzOwen N. WitteMelissa McCrackenTove OlafsenAndré E. NelXiang Wang
- Topics
- Monoclonal and Polyclonal Antibodies Research (10 papers)Radiopharmaceutical Chemistry and Applications (9 papers)Immunotherapy and Immune Responses (8 papers)
- Journals
- Proceedings of the National Academy of SciencesAngewandte Chemie International EditionNature Communications
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Felix B. Salazar
29 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 700
- Immunology 605
- Biomedical Engineering 516
- Radiology, Nuclear Medicine and Imaging 471
- Molecular Biology 371
Countries citing papers authored by Felix B. Salazar
This map shows the geographic impact of Felix B. Salazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix B. Salazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix B. Salazar more than expected).
Fields of papers citing papers by Felix B. Salazar
This network shows the impact of papers produced by Felix B. Salazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix B. Salazar. The network helps show where Felix B. Salazar may publish in the future.
Co-authorship network of co-authors of Felix B. Salazar
This figure shows the co-authorship network connecting the top 25 collaborators of Felix B. Salazar. A scholar is included among the top collaborators of Felix B. Salazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix B. Salazar. Felix B. Salazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 62 | |
| 6 | 11 | |
| 7 | 45 | |
| 8 | 10 | |
| 9 | 68 | |
| 10 | Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppressionbreakdown → | 399 |
| 11 | 237 | |
| 12 | 91 | |
| 13 | 25 | |
| 14 | 50 | |
| 15 | 12 | |
| 16 | 26 | |
| 17 | 28 | |
| 18 | 50 | |
| 19 | 63 | |
| 20 | 36 |
About Felix B. Salazar
Felix B. Salazar is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Immunology (605 citations), Oncology (700 citations) and Radiology, Nuclear Medicine and Imaging (471 citations). Felix B. Salazar has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include Anna M. Wu, Richard Tavaré, Kirstin A. Zettlitz, Owen N. Witte, Melissa McCracken, Tove Olafsen, André E. Nel, Xiang Wang, Scott M. Knowles and Xiangsheng Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.